MedPath

Found 556472 clinical trials

Sort by:

A Two-Part Phase 3 Study of LY4170156 in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer

Not Applicable

Not yet recruiting

Conditions: Ovarian Neoplasms
Fallopian Tube Neoplasms
Peritoneal Neoplasms
Neoplasm Metastasis

Interventions: Drug: LY4170156
Drug: Paclitaxel
Drug: Topotecan
Drug: Bevacizumab
Drug: Gemcitabine
Drug: Pegylated liposomal doxorubicin
Drug: MIRV
Drug: Carboplatin

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Eli Lilly and Company

Target Recruit Count: 1080

Registration Number: NCT07213804

Locations: 🇺🇸
HonorHealth, Phoenix, Arizona, United States
🇺🇸
Sansum Clinic, Solvang, California, United States
🇺🇸
Illinois Cancer Specialists, Arlington Heights, Illinois, United States

and more 29 locations

Mediterranean Dietary Intervention on ROS Levels and TAC During Pregnancy

Not Applicable

Completed

Conditions: Healthy Pregnant Women

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of Western Macedonia

Target Recruit Count: 80

Registration Number: NCT07214402

Locations: 🇬🇷
University of Western Macedonia, Ptolemaida, Greece

High Velocity Nasal Insufflation Versus Continuous Positive Airway Pressure in COVID 19 Pneumonic Patients

Not Applicable

Completed

Conditions: COVID-19 Pneumonia

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Mansoura University

Target Recruit Count: 108

Registration Number: NCT07213518

Locations: 🇪🇬
Mohamed AbdElmoniem, Al Mansurah, Egypt

Digital Inhaler Use in Obstructive Lung Disease Care

Not Applicable

Not yet recruiting

Conditions: Chronic Obstructive Airways Disease Exacerbated
Chronic Obstructive Airway Disease

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 20

Registration Number: NCT07214337

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Not Applicable

Not yet recruiting

Conditions: Ovarian Neoplasms
Colorectal Neoplasms
Esophageal Neoplasms
Stomach Neoplasms
Breast Neoplasms
Pancreatic Intraductal Neoplasms
Cholangiocarcinoma

Interventions: Drug: LY4337713

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Eli Lilly and Company

Target Recruit Count: 241

Registration Number: NCT07213791

Locations: 🇺🇸
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸
Biogenix Molecular, LLC, Miami, Florida, United States

and more 13 locations

Virtual Reality, Music, and Education to Reduce Anxiety in Patients Undergoing Ingrown Toenail Surgery

Not Applicable

Not yet recruiting

Conditions: Ingrown Toenail

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of Seville

Target Recruit Count: 175

Registration Number: NCT07214116

Topical Amitriptyline 1% Gel for the Treatment of Burning Mouth Syndrome

Completed

Conditions: Burning Mouth Syndrome
Stomatodynia

Interventions: Drug: Topical amitriptyline 1% gel

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Universidad de Murcia

Target Recruit Count: 30

Registration Number: NCT07214181

Locations: 🇪🇸
Clinica Odontologica Universitaria, Murcia, Murcia, Spain

Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder

Not Applicable

Not yet recruiting

Conditions: Bipolar Disorder (BD)
Psychosis

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: McMaster University

Target Recruit Count: 10

Registration Number: NCT07213492

Locations: 🇨🇦
St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada

Prospective Multi-center Single Arm Study for Subjects With Chronic Subdural Hematoma Treated With i-ED COILs, Either Alone or in Combination With Burr-holes or Mini-craniotomy

Not yet recruiting

Conditions: Chronic Subdural Hematoma
cSDH
Chronic Subdural Hematomas

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Kaneka Medical America LLC

Target Recruit Count: 200

Registration Number: NCT07214623

Locations: 🇺🇸
Westchester Medical Center, Valhalla, New York, United States
🇺🇸
University of Pennslyvania, Philadelphia, Pennsylvania, United States

PRoducing Outcome Measures for OTP Quality Improvement

Not Applicable

Not yet recruiting

Conditions: Opioid Use Disorder

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: RTI International

Target Recruit Count: 4500

Registration Number: NCT07214389

Locations: 🇺🇸
RTI International, Research Triangle Park, North Carolina, United States

AI-Powered Research

Premium Access

A Two-Part Phase 3 Study of LY4170156 in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer

Mediterranean Dietary Intervention on ROS Levels and TAC During Pregnancy

High Velocity Nasal Insufflation Versus Continuous Positive Airway Pressure in COVID 19 Pneumonic Patients

Digital Inhaler Use in Obstructive Lung Disease Care

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Virtual Reality, Music, and Education to Reduce Anxiety in Patients Undergoing Ingrown Toenail Surgery

Topical Amitriptyline 1% Gel for the Treatment of Burning Mouth Syndrome

Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder

Prospective Multi-center Single Arm Study for Subjects With Chronic Subdural Hematoma Treated With i-ED COILs, Either Alone or in Combination With Burr-holes or Mini-craniotomy

PRoducing Outcome Measures for OTP Quality Improvement

Product

Company

Legal